| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 12 | +41.67% | -0.38% | +0.01% | -0.39% | +0.46% | — |
| 14d | 12 | +75.00% | +0.95% | +0.17% | +0.78% | -5.04% | — |
| 30d | 12 | +66.67% | +9.56% | +0.91% | +8.65% | +1.81% | — |
| 60d | 12 | +50.00% | +4.52% | +3.68% | +0.84% | -1.25% | — |
| 90d | 12 | +50.00% | -6.50% | +4.45% | -16.57% | -30.00% | — |
| 180d | 12(1 pending) | +72.73% | -20.46% | +6.63% | -27.09% | -36.03% | — |
| 1y | 12(1 pending) | +90.91% | -34.69% | +15.57% | -50.26% | -42.54% | — |
| 2y | 12(1 pending) | +54.55% | -0.01% | +33.39% | -33.40% | -59.26% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| LONA LEONABIO, INC. | PURCHASEGRANT Stock grant | 350,000 | — | — | 350,000 | Apr 9, 2026 | Apr 13, 2026 ↗ | View → |
| LONA LEONABIO, INC. | SALE CHIEF MEDICAL OFFICER | 1,720 | $5.37 | $9.2K | 15,887 | Mar 4, 2026 | Mar 5, 2026 ↗ | View → |
| LONA LEONABIO, INC. | SALE CHIEF MEDICAL OFFICER | 7,418 | — | — | 0 | Mar 3, 2026 | Mar 5, 2026 ↗ | View → |
| LONA LEONABIO, INC. | PURCHASE CHIEF MEDICAL OFFICER | 7,418 | — | — | 17,607 | Mar 3, 2026 | Mar 5, 2026 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 3,100 | $35.03 | $108.6K | 202,900 | Jan 5, 2024 | Jan 5, 2024 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 800 | $34.11 | $27.3K | 206,000 | Jan 5, 2024 | Jan 5, 2024 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 4,403 | $35.64 | $156.9K | 198,497 | Jan 5, 2024 | Jan 5, 2024 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 206,800 | Jan 4, 2024 | Jan 5, 2024 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 4,942 | $29.00 | $143.3K | 131,800 | Nov 20, 2023 | Nov 21, 2023 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 14,758 | $28.73 | $424.0K | 136,742 | Nov 20, 2023 | Nov 21, 2023 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 151,500 | Jan 4, 2023 | Jan 5, 2023 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 19,300 | $29.98 | $578.6K | 91,700 | Nov 21, 2022 | Nov 22, 2022 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 200 | $30.62 | $6.1K | 91,500 | Nov 21, 2022 | Nov 22, 2022 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 5,696 | $70.01 | $398.8K | 111,100 | Nov 19, 2021 | Nov 22, 2021 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 13,704 | $69.01 | $945.7K | 116,796 | Nov 19, 2021 | Nov 22, 2021 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 100 | $70.99 | $7.1K | 111,000 | Nov 19, 2021 | Nov 22, 2021 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 19,500 | $69.39 | $1.35M | 130,500 | Nov 19, 2020 | Nov 20, 2020 ↗ | View → |